These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23741829)

  • 1. A multicentric, open label, randomised, postmarketing efficacy study comparing multidose of lincomycin hydrochloride capsule 500 mg with multidose cefpodoxime proxetil tablet 200 mg in patients with tonsillitis, sinusitis.
    Kothadiya A
    J Indian Med Assoc; 2012 Aug; 110(8):580-3. PubMed ID: 23741829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of oral cefpodoxime proxetil and penicillin V potassium in the treatment of group A streptococcal pharyngitis/tonsillitis. The Cefpodoxime Pharyngitis Study Group.
    Brown RJ; Batts DH; Hughes GS; Greenwald CA
    Clin Ther; 1991; 13(5):579-88. PubMed ID: 1799915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin.
    Portier H; Chavanet P; Waldner-Combernoux A; Kisterman JP; Grey PC; Ichou F; Safran C
    Scand J Infect Dis; 1994; 26(1):59-66. PubMed ID: 8191242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefpodoxime proxetil vs. penicillin V in pediatric streptococcal pharyngitis/tonsillitis.
    Dajani AS; Kessler SL; Mendelson R; Uden DL; Todd WM
    Pediatr Infect Dis J; 1993 Apr; 12(4):275-9. PubMed ID: 8483620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.
    Fulton B; Perry CM
    Paediatr Drugs; 2001; 3(2):137-58. PubMed ID: 11269640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective short-course treatment of acute group A beta-hemolytic streptococcal tonsillopharyngitis. Ten days of penicillin V vs 5 days or 10 days of cefpodoxime therapy in children.
    Pichichero ME; Gooch WM; Rodriguez W; Blumer JL; Aronoff SC; Jacobs RF; Musser JM
    Arch Pediatr Adolesc Med; 1994 Oct; 148(10):1053-60. PubMed ID: 7921095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cefpodoxime proxetil with cefaclor in the treatment of sinusitis.
    Gehanno P; Depondt J; Barry B; Simonet M; Dewever H
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():87-91. PubMed ID: 2127269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of cefpodoxime proxetil on the treatment of bacterial infections].
    Li JT; Hou J; Kao L
    Zhonghua Nei Ke Za Zhi; 1994 Jul; 33(7):440-3. PubMed ID: 7867436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of acute maxillary sinusitis in adults. Comparison of cefpodoxime-proxetil and amoxicillin-clavulanic acid].
    Polonovski JM; El Mellah M
    Presse Med; 2006 Jan; 35(1 Pt 1):33-8. PubMed ID: 16462661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharyngitis/tonsillitis: European and United States experience with cefpodoxime proxetil.
    Dajani AS
    Pediatr Infect Dis J; 1995 Apr; 14(4 Suppl):S7-11. PubMed ID: 7792129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefpodoxime proxetil: dosage, efficacy and tolerance in adults suffering from respiratory tract infections.
    Safran C
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():93-101. PubMed ID: 2292535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of josamycin for the treatment of scarlet fever and hemolytic-streptococcal tonsillitis].
    Yanagishita T; Shimizu N; Ono T
    Nihon Densenbyo Gakkai Zasshi; 1969 Nov; 43(8):205-12. PubMed ID: 4983145
    [No Abstract]   [Full Text] [Related]  

  • 13. Five day treatment of pharyngotonsillitis with cefpodoxime proxetil.
    Portier H; Chavanet P; Gouyon JB; Guetat F
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():79-85. PubMed ID: 2127268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative trial of the clinical efficacy and tolerance of cefatrizine (Cefaperos) and cefpodoxime proxetil (Orelox) in superinfections of chronic obstructive bronchopneumopathies in adults in urban practice].
    Brambilla C; Benhamou D; Guérin JC; Kelkel E; Muir JF; Prud'homme A; Taytard A; Fauche A
    Pathol Biol (Paris); 1995 Nov; 43(9):815-24. PubMed ID: 8746104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cefpodoxime proxetil and cefixime in the treatment of acute otitis media in infants and children. Otitis Study Group.
    Asmar BI; Dajani AS; Del Beccaro MA; Mendelman PM
    Pediatrics; 1994 Dec; 94(6 Pt 1):847-52. PubMed ID: 7971000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
    Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
    Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infections.
    Balfour JA; Benfield P
    Pharmacoeconomics; 1996 Aug; 10(2):164-78. PubMed ID: 10163419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of cefpodoxime proxetil in the pediatric field].
    Niino K; Sato H; Narita A; Nakazawa S; Suzuki H; Matsumoto K; Nakazawa S
    Jpn J Antibiot; 1989 Jul; 42(7):1505-18. PubMed ID: 2810727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of clindamycin in the treatment of scarlet fever and hemolytic-streptococcal tonsillitis].
    Yanagishita T; Shimizu N; Ono T
    Kansenshogaku Zasshi; 1971 Jul; 45(7):285-94. PubMed ID: 5000005
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of efficacy, safety and dosage on cefpodoxime proxetil in pediatric infections].
    Hirosawa H; Ishikawa Y; Takahashi S; Matsuda H; Ichihashi H
    Jpn J Antibiot; 1989 Jul; 42(7):1498-504. PubMed ID: 2810726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.